Events reported upon discontinuation of treatment with immediate-release paroxetine hydrochloride in the pediatric clinical trials that included a taper phase regimen, which occurred in at least 2 of patients who received immediate-release paroxetine hydrochloride and which occurred at a rate at least twice that of placebo, were emotional lability including suicidal ideation, suicide attempt, mood changes, and tearfulness , nervousness, dizziness, nausea, and abdominal pain see discontinuation of treatment with paroxetine hydrochloride controlled-release tablets .

Abnormal heartbeats may occur when clarithromycin is combined with some drugs, such as amiodarone cordarone , quinidine quinidex , amitriptyline elavil , fluconazole diflucan , citalopram celexa , trazodone oleptro , or disopyramide norpace .